Skip Navigation

Correction for Twombly, J. Natl. Cancer Inst. 94 (7) 474-475.
JNCI Journal of the National Cancer Institute 2002 94(10):717; doi:10.1093/jnci/94.10.717
© 2002 by Oxford University Press
This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of the National Cancer Institute, Vol. 94, No. 10, 717, May 15, 2002
© 2002 Oxford University Press

NEWS

Correction

An April 3 News story ("Upstaging Tamoxifen? New Classes of Drugs Emerging for Breast Cancer", p. 474) incorrectly summarized the results of the Arimidex and Tamoxifen Alone or in Combination (ATAC) clinical trial. The trial found that, compared with tamoxifen alone, the aromatase inhibitor anastrozole statistically significantly reduced the relative risk of disease recurrence in postmenopausal women with early-stage breast cancer. The combination of anastrozole and tamoxifen was not statistically significantly different from tamoxifen alone. The Journal regrets the error.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Extract Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?